Morning Movers 1/27: CV Therapeutics (CVTX) Surges On Takeover Bid, Verizon (VZ) Lower After Results Jan 27, 2009 09:56AM

StreetInsider.com Morning Movers:

CV Therapeutics, Inc. (Nasdaq: CVTX) 40% HIGHER; Japanese drugmaker Astellas Phama has offered to acquire CV Therapeutics, Inc. (Nasdaq: CVTX) for $16 per share, which is a nice premium to yesterday's $11.35 per share closing. CV Therapeutics rejected the overture.

Phoenix Technologies (Nasdaq: PTEC) 29% LOWER; reports Q4 loss of $0.18, 8 cents below the analyst estimate of ($0.10). Revenue for the quarter was $17.4 million, versus the consensus of $18.75 million.

Zions Bancorp (Nasdaq: ZION) 19% HIGHER; reports Q4 loss of $0.32, 2 cents lower than the analyst estimate of ($0.30).

Netflix (Nasdaq: NFLX) 17% HIGHER; reports Q4 EPS of $0.41, 7 cents better than the analyst estimate of $0.34. Revenue for the quarter was $359.6 million, versus the consensus of $354.18 million. Netflix sees Q1 EPS 25c to 33c versus 30c consensus. Sees Q1 revenue $387M to $393M versus $371.5M. Sees FY09 EPS $1.43 to $1.59 ...